FAIR VALUE MEASUREMENTS (Tables)

3 Months Ended

Mar. 31, 2023

Fair Value Disclosures [Abstract]

SCHEDULE OF FINANCIAL INSTRUMENT MEASURED ON RECURRING BASIS

	As of March 31, 2023				Fair Value Measurements
			Fair		As of March 31, 2023
	Amount		Value		Level 1		Level 2		Level 3
Liabilities:
Contingent consideration:
Asuragen (1)	$	933	$	933	$	-	$	-	$	933
Note payable:
BroadOak loan		10,000		11,132		-		-		11,132
	$	10,933	$	12,065	$	-	$	-	$	12,065

(1) See Note 10, Other Accrued Expenses

	As of December 31, 2022				Fair Value Measurements
			Fair		As of December 31, 2022
	Amount		Value		Level 1		Level 2		Level 3
Liabilities:
Contingent consideration:
Asuragen (1)	$	1,088	$	1,088	$	-	$	-	$	1,088
Note payable:
BroadOak loan		10,000		11,165		-		-		11,165
	$	11,088	$	12,253	$	-	$	-	$	12,253

(1) See Note 10, Other Accrued Expenses

SCHEDULE OF FAIR VALUE, ASSETS MEASURED ON RECURRING BASIS, UNOBSERVABLE INPUT RECONCILIATION

A roll forward of the carrying value of the Contingent Consideration Liability and BroadOak loans to March 31, 2023 is as follows:

										Adjustment
	December 31,				Transferred to Accrued			Accretion/ Interest		to Fair Value/ Mark to			March 31,
	2022		Issued		Expenses			Accrued		Market			2023
Asuragen	$	1,088	$	-	$	(190	)	$	35	$	-		$	933
BroadOak loans		11,165		-		-			-		(33	)		11,132
	$	12,253	$	-	$	(190	)	$	35	$	(33	)	$	12,065